Acid Reducers Do Not Impact VEGF Inhibitor Efficacy in Metastatic RCC
The use of proton pump inhibitors does not appear to impact the efficacy of oral VEGF tyrosine kinase inhibitors in metastatic renal cell carcinoma, according to a new study.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Dave Levitan Tags: Genitourinary Cancers Conferences/IKCS 2016 Kidney Cancer News Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Conferences | Kidney Cancer | Oral Cancer | Renal Cell Carcinoma | Study | Urology & Nephrology